E-mail us:
service@prospectnews.com
Or call: 212 374 2800
Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
Add to balance / Manage account
Not logged in
Prospect News home
>
Main news index
>
All issuers starting with B
>
Issuers starting with B, PP only
>
All stories on Beijing Med-Pharm Corp.
>
Stories on Beijing Med-Pharm Corp., PP only
Search again
Enter part or all of the issuer name:
Market:
All markets
No structured products
Bank loans
Canadian bonds
CLOs
Convertibles
Distressed debt
Emerging markets
High yield
Investment grade
Liability management
Municipals
PIPEs
Preferreds
Private placements
All leveraged markets
Structured products
Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each.
All others are $1.00 each. Headlines in
gray
are not currently covered by your subscription.
Beijing Med-Pharm Corp.
11/6/2007
PP
New Issue: Beijing Med-Pharm settles $23.13 million sale of notes, warrants
8/21/2007
PP
New Issue: Beijing Med-Pharm plans $32.61 million placement of units
8/21/2007
PP
Market Commentary:
Beijing Med-Pharm announces $32.61 million sale; Qiao Xing Universal Telephone pockets $25 million
12/20/2006
PP
New Issue: Beijing Med-Pharm raises $15 million from stock sale
12/20/2006
PP
Market Commentary:
Plains All American raises $300 million; Nova Biosource preps $47.09 million stock sale
10/19/2005
BTPP
New Issue: Beijing Med-Pharm wraps $6.3 million private placement of stock
10/19/2005
PP
Market Commentary:
Crosstex secures $105 million for acquisition; Hana Biosciences leads biopharmaceutical offerings
©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.